Global Epharmacy Market Set To Grow At A Cagr Of 16.7% From 2017-2022

03 August 2017
Pharma

Visiongain’ has launched a new pharma report Global ePharmacy Market 2018-2028: US, Canada, Mexico, UK, Germany, Italy, France, Spain, Portugal, India, China, Japan, Australia, GCC, Egypt, South Africa
ePharmacy or online pharmacy or internet pharmacy as it is sometimes called is an internet-based service where vendors can sell various pharmaceutical products both legally or illegally. The current report is an estimation of the legal online pharmacy market. Most pharmaceutical chains are trying to have their online portal to help in establishing a global reach for dispensing drugs. The market however is very sensitive owing to the regulations which though are already established in the developed countries of North America and Europe, is still being framed in emerging countries such as India and China.

The lead analyst of this report commented “ePharmacy has been seen for many years as an upcoming and potentially transformative technology. Factors such as the developing regulations of online pharmacy in developing countries, growing economic feasibility, cheap prices of generic drugs and the ease of ordering medicines from home is going to benefit the growth of the market.

However, the industry has many barriers to overcome. Current reimbursement and regulatory systems, threat of illegal pharmacies and increasing risk of drug abuse. In addition, entry of big e-commerce giants like Amazon and Walmart will also pose a threat to the existing market players.”

Leading companies featured in the report include DocMorris, CVS Caremark, Lloyds Pharma
Walgreens Boots Alliance, Pharmacy2U, Rowlands Pharmacy

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongainglobal.com or call her on +44 (0) 207 336 6100

About visiongain
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, visiongain produces a host of business-to-business reports cusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

Visiongain Publishes OTC Drugs & Dietary Supplements Market Report 2020-2030

The increasing rates of patent expiry lead to a counter-strategy of switching companies from Rx to OTC. In the US, according to the Consumer Healthcare Products Association, approximately 106 ingredients and dosage strengths have undergone a change from Rx to OTC to around 700 OTC products on the market.

23 September 2020

Read

Visiongain Publishes Healthcare Cold Chain Logistics Market Report 2020-2030

. The growth of this market is majorly driven by increasing sales of temperature sensitive pharmaceutical products, longer life expectancy and rising geriatric population are some of the prominent factors.

16 September 2020

Read

Visiongain Publishes Vaccines Sales Market Report 2020-2030

Visiongain forecasts a continuing growth in global market, submarket and product sales as human vaccines drive pharmaceutical business sales. New key players and technological progress will enter the industry, leading to an increase in the market size of the world market for human vaccines in general.

14 September 2020

Read

Visiongain Publishes Ophthalmic Ultrasound Systems Market Report 2020-2030

The global ophthalmic ultrasound systems market is driven by factors such as the increasing prevalence of ocular disorders and diseases, adoption of novel ophthalmic technologies, rising focus on research & development, and growing health awareness amongst the population.

09 September 2020

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever